BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36762925)

  • 1. Advances in Genetic Editing of the Human Embryo.
    Astarăstoae V; Ioan BG; Rogozea LM; Hanganu B
    Am J Ther; 2023 Mar-Apr 01; 30(2):e126-e133. PubMed ID: 36762925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline Editing: Editors Cautionary.
    Krishan K; Kanchan T; Singh B; Baryah N; Puri S
    Clin Ter; 2018; 169(2):e58-e59. PubMed ID: 29595865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome Editing of Monogenic Neuromuscular Diseases: A Systematic Review.
    Long C; Amoasii L; Bassel-Duby R; Olson EN
    JAMA Neurol; 2016 Nov; 73(11):1349-1355. PubMed ID: 27668807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.
    Musunuru K
    J Am Coll Cardiol; 2017 Dec; 70(22):2808-2821. PubMed ID: 29191331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery technologies for genome editing.
    Yin H; Kauffman KJ; Anderson DG
    Nat Rev Drug Discov; 2017 Jun; 16(6):387-399. PubMed ID: 28337020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic gene editing: delivery and regulatory perspectives.
    Shim G; Kim D; Park GT; Jin H; Suh SK; Oh YK
    Acta Pharmacol Sin; 2017 Jun; 38(6):738-753. PubMed ID: 28392568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can genetic engineering-based methods for gene function identification be eclipsed by genome editing in plants? A comparison of methodologies.
    Amritha PP; Shah JM
    Mol Genet Genomics; 2021 May; 296(3):485-500. PubMed ID: 33751237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Germline Genome Editing.
    Ormond KE; Mortlock DP; Scholes DT; Bombard Y; Brody LC; Faucett WA; Garrison NA; Hercher L; Isasi R; Middleton A; Musunuru K; Shriner D; Virani A; Young CE
    Am J Hum Genet; 2017 Aug; 101(2):167-176. PubMed ID: 28777929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Genome Editing and Ethical Considerations.
    Krishan K; Kanchan T; Singh B
    Sci Eng Ethics; 2016 Apr; 22(2):597-9. PubMed ID: 26154417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethics of Human Genome Editing.
    Coller BS
    Annu Rev Med; 2019 Jan; 70():289-305. PubMed ID: 30691366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome Editing for Longer Lives: The Problem of Loneliness.
    Wareham CS
    J Bioeth Inq; 2020 Jun; 17(2):309-314. PubMed ID: 32152896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research advance and application in the gene therapy of gene editing technologies].
    Ren YX; Xiao RD; Lou XM; Fang XD
    Yi Chuan; 2019 Jan; 41(1):18-27. PubMed ID: 30686782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.
    Sanjurjo-Soriano C; Kalatzis V
    Neural Plast; 2018; 2018():5056279. PubMed ID: 29853845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-viral strategies for delivering genome editing enzymes.
    Li J; Røise JJ; He M; Das R; Murthy N
    Adv Drug Deliv Rev; 2021 Jan; 168():99-117. PubMed ID: 32931860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the Toolbox and Targets for Gene Editing.
    Dan J; Memczak S; Izpisua Belmonte JC
    Trends Mol Med; 2021 Mar; 27(3):203-206. PubMed ID: 33487569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-viral delivery of genome-editing nucleases for gene therapy.
    Wang M; Glass ZA; Xu Q
    Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses.
    Gilani U; Shaukat M; Rasheed A; Shahid M; Tasneem F; Arshad M; Rashid N; Shahzad N
    J Med Virol; 2019 Jan; 91(1):1-13. PubMed ID: 30133783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A beginner's guide to gene editing.
    Harrison PT; Hart S
    Exp Physiol; 2018 Apr; 103(4):439-448. PubMed ID: 29282799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.